Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study
Gaetano Alfano(University of Modena and Reggio Emilia), Gabriele Donati(University of Modena and Reggio Emilia), Francesco Fontana(Ospedale di Monfalcone), Riccardo Magistroni(University of Modena and Reggio Emilia), Laura Tonelli(University of Modena and Reggio Emilia), Erica Franceschini(University of Modena and Reggio Emilia), Martina Montani(University of Modena and Reggio Emilia), Roberta Scarmignan(University of Modena and Reggio Emilia), Gianni Cappelli(FIND), Silvia Giovanella(University of Modena and Reggio Emilia), Niccolò Morisi(Azienda Ospedaliero-Universitaria di Modena), Camilla Ferri(IRCCS Ospedale San Raffaele), Giovanni Guaraldi(University of Modena and Reggio Emilia), Giacomo Mori(University of Modena and Reggio Emilia), Giulia Ligabue(University of Modena and Reggio Emilia)
Cited by 4
Related Papers
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424